Search Results - "ARKFELD, D. G"

Etanercept therapy in rheumatoid arthritis: A randomized, controlled trial by MORELAND, L. W, SCHIFF, M. H, RUDERMAN, E. M, HORWITZ, D. A, ARKFELD, D. G, GARRISON, L, BURGE, D. J, BLOSCH, C. M, LANGE, M. L. M, MCDONNELL, N. D, WEINBLATT, M. E, BAUMGARTNER, S. W, TINDALL, E. A, FLEISCHMANN, R. M, BULPITT, K. J, WEAVER, A. L, KEYSTONE, E. C, FURST, D. E, MEASE, P. J

“…In a phase II study, etanercept (recombinant human tumor necrosis factor receptor [p75]:Fc fusion protein) safely produced rapid, dose-dependent improvement in…”
Get full text

The use of the tumour necrosis factor antagonist infliximab in heart transplant recipients: two case reports by Metyas, S, La, D, Arkfeld, D G

“…Interestingly, TNF has been suggested to have a protective negative inotropic action on the failing heart, contradicting the previous paradigm of TNF being…”
Get full text

Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis by Metyas, S. K., Tadros, R. M., Arkfeld, D. G.

Get full text

The potential utility of B cell-directed biologic therapy in autoimmune diseases by Arkfeld, D. G.

“…Increasing awareness of the importance of aberrant B cell regulation in autoimmunity has driven the clinical development of novel B cell-directed biologic…”
Get full text

Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis by Metyas, S. K., Tadros, R. M., Arkfeld, D. G.

“…Sarcoidosis is a multisystemic disease characterized by noncaseating granulomatous infiltration, primarily of the lungs and lymphatic system. While reports of…”
Get full text

Quest for the Holy Grail to cure arthritis and osteoporosis: Emphasis on bone drug delivery systems by Arkfeld, Daniel G., Rubenstein, Elyse

“…The number of new medications to treat and even prevent arthritis and osteoporosis has expanded dramatically in recent years. Where once there were only…”
Get full text

Treatment of Rheumatoid Arthritis by Stohl, W, Arkfeld, D G

“…To the Editor: O'Dell et al. (May 16 issue) 1 addressed the important topic of optimal therapy for rheumatoid arthritis. However, we are concerned that the…”
Get full text

271 CUTANEOUS REACTION PATTERNS ASSOCIATED WITH INFLIXIMAB THERAPY by Kokhab, M., Torralba, K. D., Metyas, S. K., Vadmal, M., Johnson, D., Arkfeld, D. G., Quismorio, F. P.

Get full text

Relating bone marrow oedema to hs-CRP in knee osteoarthritis by Bassiouni, H, Zaki, K, Elshorbagi, M, Mustapha, A, Tantawi, R, Ali, H, Metyas, S, Arkfeld, DG

“…Abstract Objective To study the correlation between bone marrow oedema (BME) on knee magnetic resonance imaging (MRI) and plasma high sensitive-CRP (hs-CRP)…”
Get full text

Identification of Neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction by Liebling, M R, Arkfeld, D G, Michelini, G A, Nishio, M J, Eng, B J, Jin, T, Louie, J S

“…To analyze synovial fluid (SF) for the presence of Neisseria gonorrhoeae DNA using the polymerase chain reaction (PCR). We used a modified, nested PCR to…”
Get more information

Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren’s Syndrome patients by Edman, Maria C., Janga, Srikanth R., Meng, Zhen, Bechtold, Mercy, Chen, Alexander F., Kim, Chongiin, Naman, Luke, Sarma, Arunava, Teekappanavar, Neha, Kim, Alice Y., Madrigal, Sara, Singh, Simranjit, Ortiz, Elizabeth, Christianakis, Stratos, Arkfeld, Daniel G., Mack, Wendy J., Heur, Martin, Stohl, William, Hamm-Alvarez, Sarah F.

“…Cathepsin S (CTSS) activity is elevated in Sjögren’s Syndrome (SS) patient tears. Here we tested whether protease inhibition and cystatin C (Cys C) levels are…”
Get full text

Low Dose Naltrexone in the Treatment of Fibromyalgia by Metyas, Samy, Chen, Christina L, Yeter, Karen, Solyman, John, Arkfeld, Daniel G

“…ConclusionFibromyalgia is a chronic pain disorder characterized by diffuse musculoskeletal pain, fatigue, sleep disturbance and cognitive impairment. A…”
Get more information

Rituximab treatment for resistant antiphospholipid syndrome by RUBENSTEIN, Elyse, ARKFELD, Daniel G, METYAS, Samy, SHINADA, Shuntaro, EHRESMANN, Sonya, LIEBMAN, Howard A

“…Antiphospholipid syndrome (APS) and catastrophic antiphospholipid syndrome (CAPS) can be challenging to treat. As they are rare, clinicians are not often…”
Get full text

Development of Crohn's disease in a patient taking etanercept by OH, Jenny, ARKFELD, Daniel G, HORWITZ, David A

“…In addition to its well known proinflammatory effects, tumor necrosis factor-alpha (TNF-a) has complex effects on the growth, differentiation, and death of…”
Get full text

CUTANEOUS REACTION PATTERNS ASSOCIATED WITH INFLIXIMAB THERAPY: 271 by Kokhab, M., Torralba, K. D., Metyas, S. K., Vadmal, M., Johnson, D., Arkfeld, D. G., Quismorio, F. P.

Get full text

Infliximab Treatment of Familial Mediterranean Fever and Its Effect on Secondary AA Amyloidosis by Metyas, Samy, Arkfeld, Daniel G, Forrester, Deborah M, Ehresmann, Glenn R

“…We describe a patient with a long history of familial Mediterranean fever who developed proteinuria as a result of secondary AA amyloidosis. In this patient,…”
Get full text

ADULT STILL'S DISEASE IN A 75-YEAR-OLD PATIENT by Rubenstein, Elyze J., Arkfeld, Daniel G.

Get full text

Myositis ossificans: A case report by Hendifar, Andrew E., Johnson, Dorothy, Arkfeld, Daniel G.

Get full text

Hip Arthroplasty in a 101-Year-Old Patient by Lacson, Stephanie M, Metyas, Samy K, Arkfeld, Daniel G

Get full text

Immune Thrombocytopenia in Patients with Connective Tissue Disorders and the Antiphospholipid Antibody Syndrome by Arkfeld, Daniel G., MD, Weitz, Ilene C., MD

“…It has been theorized that immune thrombocytopenia (ITP) is a syndrome characterized by various defects in immune regulation, resulting in a common phenotype,…”
Get full text